NIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy.
conference contribution
posted on 2023-05-18, 06:05 authored by Paul Mitchell, Shankar Siva, Peey Sei Kok, Ken O'Byrne, Annie Yeung, Ann Livingstone, Mark Donoghoe, Sonia Yip, Martin R StockierNIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy.
